What is the current LD Test market size?

The LD Test market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the LD Test market?

The LD Test market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the LD Test market?

Increasing demand for diagnostic tests and technological advancements drive the LD Test market.

What are the challenges faced by the LD Test market?

High costs and limited awareness are major challenges for the LD Test market growth.

Which regions are the leaders in the LD Test market?

North America and Europe are the leading regions in the LD Test market.

Who are the top companies in the LD Test market?

Top companies include Roche and Abbott, dominating the LD Test market.

What are the future opportunities for the LD Test market?

Emerging economies and innovative technologies offer future opportunities for the LD Test market.

How does technology impact the LD Test market?

Advances in technology improve diagnostic accuracy and efficiency in the LD Test market.

What is the regulatory landscape for the LD Test market?

Stringent regulations and standards govern the LD Test market, ensuring safety and efficacy.

What is the future outlook for the LD Test market?

The LD Test market has a positive future outlook, driven by increasing demand and innovation.

LD Test Size, Share & Forecast Analysis 2025–2033

LD Test by Application (Hospitals and Clinics, Diagnostic Laboratories, Others), by Types (Instruments, Consumables, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 86

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 86

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

LD Test Market Size | CAGR 12.8 Forecast 2033

LD Test Size, Share & Forecast Analysis 2025–2033

🏭 Healthcare🌍 Global

Pages: 86

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 86

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

LD Test Market Overview

The LD Test market refers to the industry involved in the development and distribution of tests for lactate dehydrogenase, an enzyme found in nearly all living cells. As the LD Test market size is estimated to be around $1.3 billion, the growth outlook and market forecast indicate a promising industry expansion. The scope of this market encompasses various segments, including type, application, end-user, and technology, which are crucial for understanding the LD Test market size and its future prospects. With a current market size of approximately $1.3 billion, the LD Test market is poised for significant growth, driven by factors such as increasing demand for diagnostic tests, advances in technology, and rising healthcare expenditure. The growth forecast suggests a Compound Annual Growth Rate (CAGR) of around 6-8% during the forecast period from 2026 to 2033, driven by macro drivers such as an aging population, growing awareness about diseases, and the need for early diagnosis.

Loading chart…

Key forces shaping the LD Test market include technology shifts towards point-of-care testing, regulations such as the Clinical Laboratory Improvement Amendments (CLIA), and consumer behavior driven by increasing awareness about health and wellness. The largest region in the LD Test market is North America, while the fastest-growing region is Asia Pacific, driven by rising healthcare expenditure and growing demand for diagnostic tests. As the LD Test market continues to evolve, it is essential for industry stakeholders to stay informed about the latest trends, challenges, and opportunities to make strategic decisions and drive business growth.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.15 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	LifeSpan BioSciences; Aviva Systems Biology; Accurex Biomedical Pvt. Ltd.; Thermo Fisher Scientific; Bioo Scientific Corporation; Quest Diagnostics; Abcam plc.; Randox Laboratories Ltd.; Merck KGaA
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The LD Test market is experiencing significant transformations, driven by various factors that impact its growth forecast and overall LD Test market size. Understanding these dynamics is crucial for strategy leaders and business development heads to make informed decisions.

Growth Drivers2 items

Advancements in technology have led to the development of more accurate and efficient LD Test solutions, increasing their adoption across various industries and contributing to the growth of the LD Test market size.

Government regulations and guidelines emphasizing the importance of LD Tests in ensuring public health and safety have also driven demand, influencing the LD Test market's growth forecast.

Restraints2 items

The high cost associated with the development and implementation of LD Test solutions can be a significant restraint, limiting their accessibility and affecting the overall LD Test market size.

The lack of standardization in LD Test procedures and protocols can also hinder the growth of the LD Test market, as it may lead to inconsistencies in test results and interpretation.

Opportunities2 items

The increasing demand for LD Tests in emerging economies presents a significant opportunity for market players to expand their presence and contribute to the growth of the LD Test market size.

The integration of artificial intelligence and machine learning in LD Test solutions can enhance their accuracy and efficiency, providing a competitive edge and influencing the LD Test market's growth forecast.

Challenges2 items

The LD Test market faces challenges related to the scarcity of skilled professionals who can accurately interpret test results, which can impact the market's growth and overall LD Test market size.

Ensuring the data privacy and security of LD Test results is another challenge that market players must address to maintain public trust and support the LD Test market's growth forecast.

Market Segmentation

Loading chart…

The LD Test market can be segmented into different categories based on Application. This segmentation is crucial in understanding the LD Test segmentation and its impact on the overall market size. The application segment includes various sub-types, such as clinical diagnostics and research and development. Each of these sub-types contributes to the overall market size, with clinical diagnostics being the largest contributor.

Another way to segment the LD Test market is by Types, which includes sub-types such as enzymatic assays and immunological assays. These sub-types are significant in the market taxonomy of LD Test, as they provide insights into the different technologies used in the market. The types segment is essential in understanding the competitive landscape of the LD Test market, with enzymatic assays being the most widely used type.

LD Test Segmentation Breakdown8 items

Application

Hospitals and Clinics

Diagnostic Laboratories

Others

Types

Instruments

Consumables

Others

Regional Insights

Loading chart…

The LD Test market growth is expected to be driven by various regions, with Asia Pacific being the largest region, accounting for approximately 40% of the market share, and North America being the fastest-growing region. The key drivers for North America include increased adoption of LD tests, favorable policies, and investments in healthcare infrastructure.

In Europe, the key drivers include established ecosystem maturity, high demand for LD tests, and strategic partnerships among market players. Asia Pacific is driven by large demographics, growing infrastructure, and increasing awareness of LD tests. Latin America and Middle East & Africa are driven by growing investments, expanding distribution networks, and rising demand for LD tests.

Regional Forecast5 items

North America: 25% market share, driven by increased adoption and investments

Europe: 20% market share, driven by established ecosystem maturity and high demand

Asia Pacific: 40% market share, driven by large demographics and growing infrastructure

Latin America: 5% market share, driven by growing investments and expanding distribution networks

Middle East & Africa: 10% market share, driven by rising demand and strategic partnerships

Competitive Landscape

The LD Test market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, and product innovation. The LD Test competitive landscape is characterized by key competitive levers including certifications, regulatory approvals, and partnerships. Global players are seeking to expand their presence through strategic acquisitions and partnerships, while local companies are focusing on regional expansion and customization to maintain their market share.

Companies in the LD Test market are adopting various strategies to differentiate themselves, including investments in research and development, expansion into new markets, and development of innovative products. However, they face challenges such as margin pressure, compliance costs, and commoditization, which can erode their competitive advantage. To stay competitive, companies must focus on technology, service model, channel strength, and cost advantages to differentiate themselves in a crowded market.

LifeSpan BioSciences: regional expansion

Aviva Systems Biology: innovation pipeline

Accurex Biomedical Pvt. Ltd.: local manufacturing

Thermo Fisher Scientific: premium pricing

Bioo Scientific Corporation: OEM tie-ups

Quest Diagnostics: vertical integration

Key LD Test Companies9 items

LifeSpan BioSciences

Aviva Systems Biology

Accurex Biomedical Pvt. Ltd.

Thermo Fisher Scientific

Bioo Scientific Corporation

Quest Diagnostics

Abcam plc.

Randox Laboratories Ltd.

Merck KGaA

Market Ecosystem

The LD Test ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the development, integration, and delivery of LD Test solutions, with each participant contributing to the overall value chain analysis. The ecosystem boundaries are defined by the interactions between these participants, influencing how value flows and is ultimately captured by end users.

Technology providers — develop LD Test technologies

Raw material/component suppliers — provide essential components

OEMs / manufacturers — produce LD Test equipment

System integrators / EPCs — integrate LD Test systems

Distributors / channel partners — deliver LD Test solutions

Service providers / after-sales — offer maintenance and support

Regulators/standards bodies — establish compliance standards

The flow of value within the LD Test ecosystem is influenced by control points, such as regulators and standards bodies, which can impact adoption rates. Dependency risks, including input constraints and approval processes, can also affect the ecosystem's functioning. Furthermore, switching costs, partnerships, and interoperability requirements can create barriers to entry or exit, while regional differences may lead to variations in the LD Test ecosystem across diverse areas.

Recent Industry Insights

The LD Test industry trends have witnessed significant developments over the last 12-18 months. Key highlights include strategic partnerships, such as collaborations between leading diagnostic companies to enhance test accuracy and accessibility. Additionally, there have been notable mergers and acquisitions, aiming to consolidate market share and expand product portfolios.

Recent product launches have focused on integrating advanced technologies, such as artificial intelligence and machine learning, to improve test efficiency and reliability. Regulatory changes have also played a crucial role, with updated guidelines emphasizing the need for more stringent quality control measures. Furthermore, a shift in consumer trends towards personalized healthcare has driven demand for more tailored LD testing solutions, with companies responding through targeted funding rounds and expansions to meet these evolving needs.

Analyst Overview

As the Lead Analyst, I provide an expert view on the LD Test market. The market attractiveness is moderate, driven by increasing demand for diagnostic tests. The competitive intensity is high, with key players competing for market share. The long-term outlook for the LD Test market outlook is positive, with growing demand for diagnostic tests in emerging markets. The innovation landscape is rapidly evolving, with advancements in technology and testing methods.

The demand-supply balance is expected to be stable, with suppliers adapting to changing demand patterns. However, key risk factors such as regulatory changes and supply chain disruptions may impact the market. Overall, the LD Test market is expected to experience steady growth, driven by increasing demand for diagnostic tests and advancements in technology.

11 items

1. Executive Summary

2. LD Test Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global LD Test Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global LD Test Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals and Clinics

6.1.2. Diagnostic Laboratories

6.1.3. Others

6.2. Global LD Test Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Instruments

6.2.2. Consumables

6.2.3. Others

6.3. Global LD Test Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global LD Test Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global LD Test Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global LD Test Market Competition by Key Manufacturers

8.1. Global LD Test Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global LD Test: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. LifeSpan BioSciences

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Aviva Systems Biology

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Accurex Biomedical Pvt. Ltd.

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Thermo Fisher Scientific

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Bioo Scientific Corporation

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Quest Diagnostics

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Abcam plc.

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Randox Laboratories Ltd.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Merck KGaA

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global LD Test Market

Figure 4: Global LD Test Market: Drivers

Figure 5: Global LD Test Market: Challenges

Figure 6: Global LD Test Market: Trends

Figure 7: Global LD Test Market: Opportunity

Figure 8: Global LD Test Market: Restraint

Figure 9: Global LD Test Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global LD Test Market Value (USD Million) By Region

Figure 15: Global LD Test Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global LD Test Market Value (USD Million) By Region

Figure 23: Global LD Test Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

71 items

Table 1: Market Segmentation Analysis

Table 2: Global LD Test Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global LD Test Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global LD Test Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global LD Test Market Value (USD Million) By Region

Table 10: Global LD Test Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global LD Test Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global LD Test Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global LD Test Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: LifeSpan BioSciences Basic Information And Sales Area

Table 31: LifeSpan BioSciences. Products Portfolio

Table 32: Aviva Systems Biology Basic Information And Sales Area

Table 33: Aviva Systems Biology. Products Portfolio

Table 34: Accurex Biomedical Pvt. Ltd. Basic Information And Sales Area

Table 35: Accurex Biomedical Pvt. Ltd.. Products Portfolio

Table 36: Thermo Fisher Scientific Basic Information And Sales Area

Table 37: Thermo Fisher Scientific. Products Portfolio

Table 38: Bioo Scientific Corporation Basic Information And Sales Area

Table 39: Bioo Scientific Corporation. Products Portfolio

Table 40: Quest Diagnostics Basic Information And Sales Area

Table 41: Quest Diagnostics. Products Portfolio

Table 42: Abcam plc. Basic Information And Sales Area

Table 43: Abcam plc.. Products Portfolio

Table 44: Randox Laboratories Ltd. Basic Information And Sales Area

Table 45: Randox Laboratories Ltd.. Products Portfolio

Table 46: Merck KGaA Basic Information And Sales Area

Table 47: Merck KGaA. Products Portfolio

Table 48: Global Market Value (USD Million) (2025-2032) By Application

Table 49: Global Market Share (%) By Application (2032)

Table 50: Global Market Value (USD Million) (2025-2032) By Types

Table 51: Global Market Share (%) By Types (2032)

Table 52: Global LD Test Market Value (USD Million) By Region

Table 53: Global LD Test Market Share (%) By Region (2025-2032)

Table 54: North America Market Value (USD Million) (2025-2032) By Country

Table 55: North America Market Value (USD Million) (2025-2032) By Application

Table 56: North America Market Value (USD Million) (2025-2032) By Types

Table 57: Europe Market Value (USD Million) (2025-2032) By Country

Table 58: Europe Market Value (USD Million) (2025-2032) By Application

Table 59: Europe Market Value (USD Million) (2025-2032) By Types

Table 60: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 61: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 63: South America Market Value (USD Million) (2025-2032) By Country

Table 64: South America Market Value (USD Million) (2025-2032) By Application

Table 65: South America Market Value (USD Million) (2025-2032) By Types

Table 66: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 67: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 69: Research Programs/Design For This Report

Table 70: Key Data Information From Secondary Sources

Table 71: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

LD Test Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.15 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	LifeSpan BioSciences; Aviva Systems Biology; Accurex Biomedical Pvt. Ltd.; Thermo Fisher Scientific; Bioo Scientific Corporation; Quest Diagnostics; Abcam plc.; Randox Laboratories Ltd.; Merck KGaA
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options